Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
World Journal of Surgical Oncology
|
June 10, 2021
Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
Haoda Chen, Fanlu Li, Siyi Zou, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
A computational medicine framework integrating multi-omics, systems biology, and artificial neural networks for Alzheimer's disease therapeutic discovery
Yisheng Yang, Yizhu Diao, Lulu Jiang, et al.
Pancreas
|
December 8, 2025
Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study
Siyi Zou, Chenlei Wen, Fanlu Li, et al.
Frontiers in Oncology
|
April 5, 2021
A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
Yangbing Jin, Zehui Zhang, Siyi Zou, et al.
International Journal of Medical Sciences
|
October 3, 2023
Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689/UBE2V1 axis and sequestering USP10
Ronghao Zhang, Xinjing Wang, Xiayang Ying, et al.
Frontiers in Immunology
|
June 8, 2023
Targeting KRAS
Qi Ai, Fanlu Li, Siyi Zou, et al.
Journal of Hematology & Oncology
|
May 7, 2022
LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Yihao Liu, Minmin Shi, Xingfeng He, et al.
Clinical and Translational Medicine
|
February 20, 2022
The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression
Yihao Liu, Xuelong Wang, Youwei Zhu, et al.
Cancer Letters
|
August 2, 2024
Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes
Siyi Zou, Lei Zhang, Cen Jiang, et al.
Frontiers in Cell and Developmental Biology
|
July 12, 2021
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
Hao Qian, Hongzhe Li, Junjie Xie, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
World Journal of Surgical Oncology
|
June 10, 2021
Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
Haoda Chen, Fanlu Li, Siyi Zou, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
A computational medicine framework integrating multi-omics, systems biology, and artificial neural networks for Alzheimer's disease therapeutic discovery
Yisheng Yang, Yizhu Diao, Lulu Jiang, et al.
Pancreas
|
December 8, 2025
Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study
Siyi Zou, Chenlei Wen, Fanlu Li, et al.
Frontiers in Oncology
|
April 5, 2021
A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
Yangbing Jin, Zehui Zhang, Siyi Zou, et al.
International Journal of Medical Sciences
|
October 3, 2023
Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689/UBE2V1 axis and sequestering USP10
Ronghao Zhang, Xinjing Wang, Xiayang Ying, et al.
Frontiers in Immunology
|
June 8, 2023
Targeting KRAS
Qi Ai, Fanlu Li, Siyi Zou, et al.
Journal of Hematology & Oncology
|
May 7, 2022
LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Yihao Liu, Minmin Shi, Xingfeng He, et al.
Clinical and Translational Medicine
|
February 20, 2022
The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression
Yihao Liu, Xuelong Wang, Youwei Zhu, et al.
Cancer Letters
|
August 2, 2024
Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes
Siyi Zou, Lei Zhang, Cen Jiang, et al.
Frontiers in Cell and Developmental Biology
|
July 12, 2021
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
Hao Qian, Hongzhe Li, Junjie Xie, et al.
Page
of 2